Medication Expert Witnesses in Massachusetts

This expert has over 30 years of experience in law enforcement with 20 of those years in the Drug Enforcement Administration. At the DEA, he worked in various positions including Resident Agent in Charge and Inspector. He currently owns a consulting & investigative services firm and works as a Private Investigator specializing in Consulting and Private and Executive Securities.

This expert is a well respected and established Professor of Law specializing in ethics of the healthcare industry. He has testified before Congress and state legislatures and served on government commissions and advisory boards, including the Food and Drug Administration. He has provided training on conflicts of interest related to pharmaceutical good governance for various nations under the aegis of the World Health Organization. He has participated in meetings of the National Academy of Sciences, Institute of Medicine and worked for the World Health Organization. He has extensive experience in the fields of health law and policy, pharmaceutical policy, biomedical law, medical ethics, and more.

This highly qualified and board certified psychiatrist has been practice for 33+ years. He earned his BS at the Massachusetts Institute of Technology and MD at Emory University. He completed residency training in psychiatry at Massachusetts General Hospital. This expert is a member of several professional organizations including the American Psychiatric Association and American Academy of Psychiatry and the Law. Currently, he is a clinical instructor at a university affiliated hospital. His clinical and forensic expertise includes assessment of complex diagnoses, treatment of depression, bipolar disorder, ADHD, and anxiety disorders. His expertise also includes dosing, side effects, drug interactions, and toxicity of psychotropic agents.

This expert has over 35 years of experience in the field of psychopharmacology. He earned his BS from Massachusetts Institute of Technology and his MD from Emory University School of Medicine. He completed an internship in general surgery at Boston University Affiliated Hospitals and a residency in psychiatry at Massachusetts General Hospital. He is a member of the American Psychiatric Association, the American Society of Clinical Psychopharmacology, and the American Academy of Psychiatry and Law. He previously served as a staff psychiatrist for Harvard Vanguard Medical Associates, as a clinical supervisor for Lane Health Center at Northeastern University and as a psychopharmacology consultant for the University of Massachusetts. This expert is currently a psychiatrist at a private practice, a staff psychiatrist at a hospital in Massachusetts and a clinical instructor of psychiatry at an Ivy League university.

This highly-qualified expert has 14 years of experience in the field of biopharmaceutical development, having earned her BS in biology from the University of North Carolina and her PhD in genetics from the University of California at San Francisco. Her work focuses on drug development with a particular focus on gene and cell therapies, including those with the following elements: AAV, Adenovirus, CRISPR, Zfn, Endonuclease, CAR-T, mRNA, LNP, Lentivirus, HSPC. She has worked in positions such as principal consultant for Halloran Consulting Group, the founder and CEO of Tremont Therapeutics, the senior director of Shire PLC, and the executive director of CRISPR Therapeutics. She is also involved in research in her field as an author of several scientific articles. This expert currently works as the principal at a drug development consulting company in Massachusetts.